Stephen Lewinton

Mr. Stephen Lewinton is Senior Vice President of UK Operations. Mr. Lewinton joined Pharmaron in February 2016 following the acquisition of Quotient Research Group Ltd and he has over 20 years of experience in contract research. Before joining Pharmaron, Mr. Lewinton was Managing Director of Quotient Bioresearch. He joined BioDynamics in 1999 and helped drive its acquisition by Quotient Bioresearch. He then ran the Drug Metabolism and Radiochemistry division and played a key role in a number of acquisitions including Amersham custom radiolabelling from GE Healthcare.

Mr. Lewinton received his MSc from University College London following a degree at Southampton University. Prior to this, he worked for a leading CROs and a virtual biotechnology company.